Related Experiment Video
Updated: Jun 29, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Stem cell mobilisation for myocardial repair
Stefan Brunner1, Markus G Engelmann, Wolfgang-Michael Franz
1Ludwig-Maximilians-University, Klinikum Grosshadern, Medical Department I, Marchioninistr. 15, 81377, Munich, Germany.
Insights
Autologous stem cell therapy shows promise for preventing heart damage after heart attacks. Mobilizing these cells, primarily through paracrine effects, enhances cardiac function and survival.
Area of Science:
- Regenerative Medicine
- Cardiovascular Biology
- Stem Cell Biology
Background:
- The transdifferentiation potential of autologous bone marrow-derived stem cells (BMCs) into cardiomyocytes or vascular cells is scientifically debated.
- Previous research has questioned the direct differentiation capacity of BMCs in cardiac repair.
Purpose of the Study:
- To review stem cell mobilization conditions and their therapeutic application in preventing ischemic cardiomyopathy post-myocardial infarction.
- To discuss the mechanisms underlying BMC mobilization and homing.
- To summarize current clinical trials investigating BMCs for cardiac repair.
Main Methods:
- Literature review of scientific reports and clinical trials.
- Discussion of stem cell mobilization, homing mechanisms, and therapeutic strategies.
- Analysis of factors influencing BMC number and function.
Main Results:
- Improved cardiac function post-BMCs migration is attributed to paracrine effects, promoting angiogenesis and preventing myocardial apoptosis.
- Circulating BMC levels correlate directly with cardiovascular risk and life expectancy.
- Physiological stimuli like exercise and hormones enhance BMC mobilization; risk factors diminish BMCs' number and function.
Conclusions:
- Autologous BMCs contribute to cardiac repair primarily through paracrine signaling, not direct differentiation.
- Factors influencing BMC mobilization and function are critical for therapeutic efficacy.
- Current cardiovascular medications appear to increase circulating BMCs, suggesting a potential benefit.
Background:
The idea that autologous bone marrow derived stem cells (BMCs) can transdifferentiate into cardiomyocytes or vascular cells has been challenged in several scientific reports.
Objective/Methods:
This review summarises conditions for stem cell mobilisation, their use for therapeutic approaches to prevent ischaemic cardiomyopathy after acute myocardial infarction and current clinical trials. Mechanisms for mobilisation and homing of BMCs are discussed.
Results/Conclusions:
The improvement in cardiac function after migration of autologous BMCs to the heart can be explained by their paracrine effects, inducing angiogenesis and preventing ischaemic myocardium from apoptosis. These effects may explain why the number of circulating BMCs is directly correlated with cardiovascular risk and life expectancy. Exercise and hormones are physiological stimuli for the mobilisation of BMCs, whereas cardiovascular risk factors severely reduce their number and functions. Current cardiovascular medications increase the amounts of autologous BMCs.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation
Stem Cell Culture
Satellite Stem Cells and Muscular Dystrophy

